Gonadotropin-releasing hormone agonist against severe aggression in autism
(2016) In BMJ Case Reports 2016.- Abstract
Aggression in patients with autism spectrum disorder (ASD) presents an important therapeutic challenge. Conventional treatment appears to be inadequate in a number of cases. The occurrence of severe aggressive symptoms since the inception of adolescence in a male patient with ASD suggested a hormonal influence by androgens. Conventional treatment with antipsychotic and antiepileptic drugs and benzodiazepines was ineffective. A subcutaneous long-acting gonadotropin-releasing hormone agonist (GnRH agonist) injection was given on a monthly basis resulting in a substantial improvement in his aggressive behaviour and renewed socialisation.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/720fe333-3e52-408d-b7ce-358934d6ef7d
- author
- Van Der Weiden, Robin M F ; Helmerhorst, Frans M. and Eriksson, Tomas LU
- organization
- publishing date
- 2016
- type
- Contribution to journal
- publication status
- published
- subject
- in
- BMJ Case Reports
- volume
- 2016
- article number
- 371
- publisher
- BMJ Publishing Group
- external identifiers
-
- pmid:27655876
- scopus:84989182977
- ISSN
- 1757-790X
- DOI
- 10.1136/bcr-2016-216378
- language
- English
- LU publication?
- yes
- id
- 720fe333-3e52-408d-b7ce-358934d6ef7d
- date added to LUP
- 2016-11-03 15:42:57
- date last changed
- 2025-01-12 14:20:08
@article{720fe333-3e52-408d-b7ce-358934d6ef7d, abstract = {{<p>Aggression in patients with autism spectrum disorder (ASD) presents an important therapeutic challenge. Conventional treatment appears to be inadequate in a number of cases. The occurrence of severe aggressive symptoms since the inception of adolescence in a male patient with ASD suggested a hormonal influence by androgens. Conventional treatment with antipsychotic and antiepileptic drugs and benzodiazepines was ineffective. A subcutaneous long-acting gonadotropin-releasing hormone agonist (GnRH agonist) injection was given on a monthly basis resulting in a substantial improvement in his aggressive behaviour and renewed socialisation.</p>}}, author = {{Van Der Weiden, Robin M F and Helmerhorst, Frans M. and Eriksson, Tomas}}, issn = {{1757-790X}}, language = {{eng}}, publisher = {{BMJ Publishing Group}}, series = {{BMJ Case Reports}}, title = {{Gonadotropin-releasing hormone agonist against severe aggression in autism}}, url = {{http://dx.doi.org/10.1136/bcr-2016-216378}}, doi = {{10.1136/bcr-2016-216378}}, volume = {{2016}}, year = {{2016}}, }